About William Grimes
Form D filings for Calosyn Pharma in 2024 list William Grimes as president and chief executive officer, director.
William Grimes first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name William Grimes in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Grimes works with at each company, as listed on that company's latest Form D.
Calosyn Pharma, Inc. · Form D, Mar 7, 2024
JL
Joseph Lovett
Director
RB
Richard Babb
Treasurer and director
DW
David Waddell
Director
RB
Ross Barrett
Secretary and director